Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proof of Concept Study for GSK2248761 in HIV-1
NCT00945282Phase 2Completed
- Sponsor
- ViiV Healthcare
- Start
- Oct 2009
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Fosdevirine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ViiV Healthcare. Started Oct 2009; status: completed.
02
Drugs
Fosdevirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00945282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00945282.